Loading…
Biosimilar competition: Early learning
Frank, Richard G., Shahzad, Mahnum, Kesselheim, Aaron S., Feldman, William
Published in Health economics (01.04.2022)
Published in Health economics (01.04.2022)
Get full text
Journal Article
Loading…
Comparison of the pharmacokinetics, safety, and immunogenicity of MSB11022, a biosimilar of adalimumab, with Humira® in healthy subjects
Hyland, Elizabeth, Mant, Tim, Vlachos, Pantelis, Attkins, Neil, Ullmann, Martin, Roy, Sanjeev, Wagner, Volker
Published in British journal of clinical pharmacology (01.10.2016)
Published in British journal of clinical pharmacology (01.10.2016)
Get full text
Journal Article
Loading…
A comparative pharmacokinetic study of DRL_BZ, a candidate biosimilar of bevacizumab, with Avastin® (EU and US) in healthy male subjects
Wynne, Chris, Schwabe, Christian, Batra, Sonica Sachdeva, Lopez‐Lazaro, Luis, Kankanwadi, Suresh
Published in British journal of clinical pharmacology (01.10.2018)
Published in British journal of clinical pharmacology (01.10.2018)
Get full text
Journal Article
Loading…
Randomised, phase I pharmacokinetic study of adalimumab biosimilar CT‐P17 (40 mg/0.4 mL) by autoinjector and prefilled syringe in healthy subjects
Davidson, Antonia, Brimhall, Darin, Kay, Jonathan, Keystone, Edward, Lee, Sang Joon, Kim, Sung Hyun, Bae, Yun Ju, Choi, Eun Jin, Furst, Daniel E.
Published in British journal of clinical pharmacology (01.11.2021)
Published in British journal of clinical pharmacology (01.11.2021)
Get full text
Journal Article
Loading…
Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar insulin N with US‐licensed Humulin® N formulation in healthy subjects: Results from the RHINE‐2 (Recombinant Human INsulin Equivalence‐2) study
Andersen, Grit, Singh, Gursharan, Murugesan, Sundara Moorthi Nainar, Gogineni, Rajesh, Sharma, Nirant, Panda, Jayanti, Marwah, Ashwani, Loganathan, Subramanian, Athalye, Sandeep N.
Published in Diabetes, obesity & metabolism (01.06.2023)
Published in Diabetes, obesity & metabolism (01.06.2023)
Get full text
Journal Article
Loading…
A Randomized Phase 1 Pharmacokinetic Study Comparing the Potential Biosimilar LRG201902 With Liraglutide (Victoza®) in Healthy Male Subjects
Mai, Gang, Fan, Lianlian, Li, Mupeng, Zhang, Peiwen, Gan, Chunyan, Huang, Qian, Shentu, Jianzhong
Published in Frontiers in pharmacology (29.01.2021)
Published in Frontiers in pharmacology (29.01.2021)
Get full text
Journal Article
Loading…
A randomized phase-I pharmacokinetic trial comparing the potential biosimilar tocilizumab (QX003S) with the reference product (Actemra®) in Chinese healthy subjects
Zhang, Hong, Li, Xiaojiao, Liu, Jingrui, Li, Cuiyun, Wu, Min, Zhu, Xiaoxue, Sun, Jixuan, Fang, Min, Ding, Yanhua
Published in Annals of medicine (Helsinki) (01.01.2021)
Published in Annals of medicine (Helsinki) (01.01.2021)
Get full text
Journal Article
Loading…
Extension Study of PF‐05280586, a Potential Rituximab Biosimilar, Versus Rituximab in Subjects With Active Rheumatoid Arthritis
Cohen, Stanley B., Burgos‐Vargas, Rubén, Emery, Paul, Jin, Bo, Cronenberger, Carol, Vázquez‐Abad, María‐Dolores
Published in Arthritis care & research (2010) (01.11.2018)
Published in Arthritis care & research (2010) (01.11.2018)
Get full text
Journal Article
Loading…
A phase I, randomized, double-blind, parallel, single-dose pharmacokinetic study to evaluate the biosimilarity of KM118 (proposed pertuzumab biosimilar) with reference pertuzumab (Perjeta ® ) in healthy male subjects
Li, Yan, Wang, Yu, Yang, Caixia, Zhao, Na, Wang, Xinghe
Published in Annals of medicine (Helsinki) (01.12.2025)
Published in Annals of medicine (Helsinki) (01.12.2025)
Get full text
Journal Article
Loading…
Loading…
Population Pharmacokinetics of CMAB008 (an Infliximab Biosimilar) and Remicade® in Healthy Subjects and Patients with Moderately to Severely Active Rheumatoid Arthritis
Su, Yin, Li, Jing, Wang, Chenguang, Zhang, Xunmin, Hou, Sheng, Guo, Huaizu, Deng, Chenhui, Ou, Lun, Wang, Jinwei
Published in Advances in therapy (01.03.2023)
Published in Advances in therapy (01.03.2023)
Get full text
Journal Article
Loading…
LZM008, a proposed tocilizumab biosimilar: Pharmacokinetics, safety, and immunogenicity profiles compared with ACTEMRA® in Chinese healthy male subjects
Cao, Guoying, Wang, Jingjing, He, Jinjie, Hu, Yingying, Yang, Haijing, Que, Linling, Gu, Xianghong, Yu, Jicheng, Wu, Xiaojie, Wu, Jufang, Fang, Wei, He, Qing, Zhang, Jing
Published in Frontiers in pharmacology (04.04.2023)
Published in Frontiers in pharmacology (04.04.2023)
Get full text
Journal Article
Loading…
Population pharmacokinetics of adalimumab biosimilar adalimumab‐adbm and reference product in healthy subjects and patients with rheumatoid arthritis to assess pharmacokinetic similarity
Kang, Jia, Eudy‐Byrne, Rena J., Mondick, John, Knebel, William, Jayadeva, Girish, Liesenfeld, Karl‐Heinz
Published in British journal of clinical pharmacology (01.11.2020)
Published in British journal of clinical pharmacology (01.11.2020)
Get full text
Journal Article
Loading…
A randomized, double-blind, parallel pharmacokinetic study comparing the trastuzumab biosimilar candidate, AryoTrust®, and reference trastuzumab in healthy subjects
Farmahini Farahani, Mohammad, Maghzi, Parnian, Jafari Aryan, Nazanin, Payandemehr, Borna, Soni, Mayur, Azhdarzadeh, Morteza
Published in Expert opinion on investigational drugs (01.12.2020)
Published in Expert opinion on investigational drugs (01.12.2020)
Get more information
Journal Article
Loading…
A randomized, double-blind, phase III study assessing clinical similarity of SB17 (proposed ustekinumab biosimilar) to reference ustekinumab in subjects with moderate-to-severe plaque psoriasis
Feldman, Steven R., Narbutt, Joanna, Girolomoni, Giampiero, Brzezicki, Jan, Reznichenko, Nataliya, Zegadło-Mylik, Maria Agnieszka, Pulka, Grazyna, Dmowska-Stecewicz, Magdalena, Kłujszo, Elżbieta, Rekalov, Dmytro, Rajzer, Lidia, Lee, Jiyoon, Lee, Minkyung, Rho, Young Hee
Published in Journal of the American Academy of Dermatology (01.09.2024)
Published in Journal of the American Academy of Dermatology (01.09.2024)
Get full text
Journal Article
Loading…
A randomised, crossover trial exploring the patient perspective and effectiveness of biosimilar adalimumab transition: IBD reference and biosimilar adalimumab cross over study (iBaSS)
Young, David, Harris, Clare, Rahmany, Sohail, Iria, Inês, Gonçalves, João, Addison, Janet, Harvey, Justin, Latter, Sue, Cummings, Fraser
Published in International journal of clinical pharmacy (01.10.2024)
Published in International journal of clinical pharmacy (01.10.2024)
Get full text
Journal Article
Loading…
AB0402 PHARMACOKINETICS AND SAFETY OF CT-P47, A PROPOSED TOCILIZUMAB BIOSIMILAR, IN COMPARISON WITH EU-APPROVED TOCILIZUMAB; A PHASE 1, RANDOMIZED, DOUBLE-BLIND, TWO-ARM, SINGLE-DOSE STUDY IN HEALTHY SUBJECTS
Yu, K. S., Kim, B., Shin, D., Park, M. K., Hwang, J. G., Kim, M., Chung, H., Ghim, J., Chung, J. Y., Smolen, J. S., Burmester, G. R., Kim, S. H., Bae, Y., Jeon, D., Yang, G., Yoo, J., Bae, J., Keystone, E.
Published in Annals of the rheumatic diseases (01.06.2023)
Published in Annals of the rheumatic diseases (01.06.2023)
Get full text
Journal Article
Loading…
Pharmacokinetic Similarity of ABP 654, an Ustekinumab Biosimilar Candidate: Results from a Randomized, Double‐blind Study in Healthy Subjects
Chow, Vincent, Mytych, Daniel T., Das, Shyamal, Franklin, Janet
Published in Clinical pharmacology in drug development (01.09.2023)
Published in Clinical pharmacology in drug development (01.09.2023)
Get full text
Journal Article
Loading…
A Randomized, Double-Blind, Efficacy and Safety Study of PF-05280586 (a Rituximab Biosimilar) Compared with Rituximab Reference Product (MabThera®) in Subjects with Previously Untreated CD20-Positive, Low-Tumor-Burden Follicular Lymphoma (LTB-FL)
Sharman, Jeff P., Liberati, Anna Marina, Ishizawa, Kenichi, Khan, Tahira, Robbins, Jeffery, Alcasid, Ann, Rosenberg, Julie Ann, Aurer, Igor
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.04.2020)
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.04.2020)
Get full text
Journal Article
Loading…
Introduction of biosimilar insulins in Europe
Davies, M., Dahl, D., Heise, T., Kiljanski, J., Mathieu, C.
Published in Diabetic medicine (01.10.2017)
Published in Diabetic medicine (01.10.2017)
Get full text
Journal Article